Sign up for free insights newsletter
AZ

Azelis Group NV

AZEBR

Need professional-grade analysis? Visit stockanalysis.com

€6.95
-4.80%
End of day
Market Cap

$1.85B

P/E Ratio

16.52

Employees

3,998

Dividend Yield

2.90%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.27-1.86-2.05-1.89-0.92-1.70
Calmar-4.53-2.20-1.57-1.00-0.32-1.50
Sharpe-2.08-1.33-1.53-1.50-0.66-1.32
Omega0.390.680.670.690.890.71
Martin-8.10-4.71-2.85-1.66-0.67-2.81
Ulcer11.0514.5023.0336.6135.3527.24

Azelis Group NV (AZE) Price Performance

Azelis Group NV (AZE) trades on BR in EUR. The company is classified in the Basic Materials sector under the Specialty Chemicals industry. The stock currently trades at EUR6.95, down 4.80% from the previous close.

Over the past year, AZE has traded between a low of EUR6.95 and a high of EUR17.59. The stock has lost 60.5% over this period. It is currently 60.5% below its 52-week high.

Azelis Group NV has a market capitalization of $1.85B, with a price-to-earnings ratio of 16.52 and a dividend yield of 2.90%.

About Azelis Group NV

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Company Info

Exchange
BR
Currency
EUR
Country
Belgium

Financial Metrics

Revenue (TTM)
$4.11B
EBITDA
$403.92M
Profit Margin
2.71%
EPS (TTM)
0.46
Book Value
11.07

Technical Indicators

52 Week High
€17.73
52 Week Low
€6.92
50 Day MA
€8.58
200 Day MA
€10.95
Beta
0.48

Valuation

Trailing P/E
16.52
Forward P/E
11.52
Price/Sales
0.45
Price/Book
0.69
Enterprise Value
$3.46B